Search Results - "García Jiménez, E S"

Hepatic manifestations and impact of COVID-19 on the cirrhotic patient by Velarde-Ruiz Velasco, J A, García-Jiménez, E S, Remes-Troche, J M

“…The novel SARS-CoV-2 coronavirus is responsible for the infectious disease caused by coronavirus 19 (COVID-19). The current pandemic is growing worldwide and…”
Get full text

Extrahepatic complications of non-alcoholic fatty liver disease: Its impact beyond the liver by Velarde-Ruiz Velasco, J A, García-Jiménez, E S, García-Zermeño, K R, Morel-Cerda, E C, Aldana-Ledesma, J M, Castro-Narro, G E, Cerpa-Cruz, S, Tapia-Calderón, D K, Mercado-Jauregui, L A, Contreras-Omaña, R

“…Non-alcoholic fatty liver disease (NAFLD) is currently one of the main causes of chronic liver disease in Western countries, with a 25% prevalence reported in…”
Get full text

Chronic nausea and vomiting syndrome and impact on quality of life by Félix-Téllez, F.A., Velarde-Ruiz Velasco, J.A., Aldana-Ledesma, J.M., García-Jiménez, E.S., Morel-Cerda, E.C., Flores-Rendón, A.R., Remes-Troche, J.M.

“…Chronic nausea and vomiting syndrome is a disorder of gut-brain interaction that affects the productive-age population. Our aim was to determine the…”
Get full text

Immune-mediated hepatitis: Basic concepts and treatment by Velarde-Ruiz Velasco, J.A., Tapia Calderón, D.K., Cerpa-Cruz, S., Velarde-Chávez, J.A., Uribe Martínez, J.F., García Jiménez, E.S., Aldana Ledesma, J.M., Díaz-González, Á., Crespo, J.

“…Immunotherapy with immune checkpoint inhibitors (ICIs) has revolutionized advanced cancer management. Nevertheless, the generalized use of these medications…”
Get full text

Beyond conventional physical examination in hepatology: POCUS by Velarde-Ruiz Velasco, J A, Tapia Calderón, D K, Llop Herrera, E, Castro Narro, G, García Jiménez, E S, Cerda Reyes, E, Higuera de la Tijera, F, Cano Contreras, A D, Moreno Alcántar, R, Chávez Ramírez, R M, Calleja Panero, J L

“…Point-of-care ultrasound (POCUS) refers to the use of ultrasound imaging through pocket-sized sonographic devices at the patient's bedside, to make a diagnosis…”
Get full text

Position paper on perioperative management and surgical risk in the patient with cirrhosis by Velarde-Ruiz Velasco, J.A., Crespo, J., Montaño-Loza, A., Aldana-Ledesma, J.M., Cano-Contreras, A.D., Cerda-Reyes, E., Fernández Pérez, N.J., Castro-Narro, G.E., García-Jiménez, E.S., Lira-Vera, J.E., López-Méndez, Y.I., Meza-Cardona, J., Moreno-Alcántar, R., Pérez-Escobar, J., Pérez-Hernández, J.L., Tapia-Calderón, D.K., Higuera-de-la-Tijera, F.

“…Management of the patient with cirrhosis of the liver that requires surgical treatment has been relatively unexplored. In Mexico, there is currently no formal…”
Get full text

Hepatic manifestations and impact of COVID-19 on the cirrhotic patient by Velarde-Ruiz Velasco, J.A., García-Jiménez, E.S., Remes-Troche, J.M.

“…The novel SARS-CoV-2 coronavirus is responsible for the infectious disease caused by coronavirus 19 (COVID-19). The current pandemic is growing worldwide and…”
Get full text

Evaluation and management of emergencies in the patient with cirrhosis by Velarde-Ruiz Velasco, J.A., García-Jiménez, E.S., Aldana-Ledesma, J.M., Tapia-Calderón, D.K., Tornel-Avelar, A.I., Lazcano-Becerra, M., Chávez-Ramírez, R.M., Cano-Contreras, A.D., Remes-Troche, J.M., Colunga-Lozano, L.E., Montaño-Loza, A.

“…The approach to and management of critically ill patients is one of the most versatile themes in emergency medicine. Patients with cirrhosis of the liver have…”
Get full text

The Mexican consensus on alcoholic hepatitis by Velarde-Ruiz Velasco, J A, Higuera-de la Tijera, M F, Castro-Narro, G E, Zamarripa-Dorsey, F, Abdo-Francis, J M, Aiza Haddad, I, Aldana Ledesma, J M, Bielsa-Fernández, M V, Cerda-Reyes, E, Cisneros-Garza, L E, Contreras-Omaña, R, Reyes-Dorantes, A, Fernández-Pérez, N J, García-Jiménez, E S, Icaza-Chávez, M E, Kershenobich-Stalnikowitz, D, Lira-Pedrín, M A, Moreno-Alcántar, R, Pérez-Hernández, J L, Ramos-Gómez, M V, Rizo-Robles, M T, Solana-Sentíes, S, Torre-Delgadillo, A

Get full text